These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 7609055

  • 1. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus.
    Bogedain C, Wolf H, Modrow S, Stuber G, Jilg W.
    J Virol; 1995 Aug; 69(8):4872-9. PubMed ID: 7609055
    [Abstract] [Full Text] [Related]

  • 2. Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.
    Pepperl S, Benninger-Döring G, Modrow S, Wolf H, Jilg W.
    J Virol; 1998 Nov; 72(11):8644-9. PubMed ID: 9765404
    [Abstract] [Full Text] [Related]

  • 3. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
    Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows JM, Moss DJ, Misko IS.
    Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
    [Abstract] [Full Text] [Related]

  • 4. Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.
    Elliott SL, Pye SJ, Schmidt C, Cross SM, Silins SL, Misko IS.
    J Infect Dis; 1997 Oct; 176(4):1068-72. PubMed ID: 9333169
    [Abstract] [Full Text] [Related]

  • 5. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
    Steven NM, Annels NE, Kumar A, Leese AM, Kurilla MG, Rickinson AB.
    J Exp Med; 1997 May 05; 185(9):1605-17. PubMed ID: 9151898
    [Abstract] [Full Text] [Related]

  • 6. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
    Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W.
    Virology; 1999 Nov 25; 264(2):289-97. PubMed ID: 10562493
    [Abstract] [Full Text] [Related]

  • 7. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
    Burrows SR, Khanna R, Burrows JM, Moss DJ.
    J Exp Med; 1994 Apr 01; 179(4):1155-61. PubMed ID: 7511682
    [Abstract] [Full Text] [Related]

  • 8. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
    Wizel B, Houghten RA, Parker KC, Coligan JE, Church P, Gordon DM, Ballou WR, Hoffman SL.
    J Exp Med; 1995 Nov 01; 182(5):1435-45. PubMed ID: 7595214
    [Abstract] [Full Text] [Related]

  • 9. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
    Sutton J, Rowland-Jones S, Rosenberg W, Nixon D, Gotch F, Gao XM, Murray N, Spoonas A, Driscoll P, Smith M.
    Eur J Immunol; 1993 Feb 01; 23(2):447-53. PubMed ID: 7679646
    [Abstract] [Full Text] [Related]

  • 10. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 11. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.
    Misko IS, Schmidt C, Honeyman M, Soszynski TD, Sculley TB, Burrows SR, Moss DJ, Burman K.
    Clin Exp Immunol; 1992 Jan 01; 87(1):65-70. PubMed ID: 1370774
    [Abstract] [Full Text] [Related]

  • 12. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
    Schmidt C, Burrows SR, Sculley TB, Moss DJ, Misko IS.
    Proc Natl Acad Sci U S A; 1991 Nov 01; 88(21):9478-82. PubMed ID: 1719531
    [Abstract] [Full Text] [Related]

  • 13. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR, Silins SL, Khanna R, Burrows JM, Rischmueller M, McCluskey J, Moss DJ.
    Eur J Immunol; 1997 Jul 01; 27(7):1726-36. PubMed ID: 9247584
    [Abstract] [Full Text] [Related]

  • 14. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
    Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP.
    J Exp Med; 1995 Dec 01; 182(6):1703-15. PubMed ID: 7500015
    [Abstract] [Full Text] [Related]

  • 15. Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.
    Reali E, Guerrini R, Giori B, Borghi M, Marastoni M, Tomatis R, Traniello S, Masucci MG, Gavioli R.
    Clin Exp Immunol; 1996 Aug 01; 105(2):369-75. PubMed ID: 8706347
    [Abstract] [Full Text] [Related]

  • 16. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
    Gavioli R, Kurilla MG, de Campos-Lima PO, Wallace LE, Dolcetti R, Murray RJ, Rickinson AB, Masucci MG.
    J Virol; 1993 Mar 01; 67(3):1572-8. PubMed ID: 7679748
    [Abstract] [Full Text] [Related]

  • 17. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.
    Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB.
    J Virol; 1993 Dec 01; 67(12):7428-35. PubMed ID: 7693972
    [Abstract] [Full Text] [Related]

  • 18. Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease.
    Misko IS, Cross SM, Khanna R, Elliott SL, Schmidt C, Pye SJ, Silins SL.
    Proc Natl Acad Sci U S A; 1999 Mar 02; 96(5):2279-84. PubMed ID: 10051632
    [Abstract] [Full Text] [Related]

  • 19. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.
    Tynan FE, Elhassen D, Purcell AW, Burrows JM, Borg NA, Miles JJ, Williamson NA, Green KJ, Tellam J, Kjer-Nielsen L, McCluskey J, Rossjohn J, Burrows SR.
    J Exp Med; 2005 Nov 07; 202(9):1249-60. PubMed ID: 16275762
    [Abstract] [Full Text] [Related]

  • 20. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
    Levitsky V, Zhang QJ, Levitskaya J, Masucci MG.
    J Exp Med; 1996 Mar 01; 183(3):915-26. PubMed ID: 8642295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.